Vnitr Lek 2006, 52(2):119-123

The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotic bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients

V. Zamrazil jr*, S. Pálová, D. Holá
Interní klinika 2. lékařské fakulty UK a FN Motol, Praha, přednosta doc. MUDr. Milan Kvapil, CSc.

Objectives:
Stress perfusion myocardial scintigraphy (SPECT) is useful in silent ischemia detection in the group of the asymptomatic type 2. diabetic patients. In our paper we present the combinations of the parameters predictive for stress myocardial SPECT result.

Methods:
We selected parameters (fibrinogen, micro/macroalbuminuria, ateroma in carotid artery bed) that were significantly associated with stress myocardial SPECT result. We analyzed the combinations of these parameters change and evaluated their significance for stress myocardial SPECT result prediction.

Results:
We evaluated 121 type 2. diabetic patients without patological ECG changes and with normal left ventricle ejection fraction. Thirty one (26 %) had abnormal and 90 (74 %) equivocal or normal stress myocardial SPECT result. The combination of ateroma presence in carotid bed and fibrinogen in upper tertile was found in 20 patients. Fifteen of them (75 %) had the abnormal SPECT result. The combinations of the ateroma absence, negative micro/macroalbuminuria and fibrinogen in the middle or lower tertile were present almost in the half of all the examined diabetic patients. Such combinations were connected with normal or equivocal SPECT result in 93-96 % cases.

Conclusion:
Micro/macroalbuminuria, fibrinogen and ateroma in carotid bed found by sonography are significantly associated with stress myocardial SPECT result. Combinations of these parameters changes lead to the futher stratification that enables the rationale approach in the stress examination indication.

Keywords: type 2 diabetes mellitus; fibrinogen; microalbuminuria; carotis artery sonography; coronary artery disease prediction

Received: October 19, 2005; Accepted: November 21, 2005; Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zamrazil V, Pálová S, Holá D. The meaning of the combination of fibrinogen, micro/macroalbuminuria and atheromatosis in the carotic bloodstream for the evaluation of the abnormal finding of the stress myocardial SPECT in the asymptomatic 2nd type diabetic patients. Vnitr Lek. 2006;52(2):119-123.
Download citation

References

  1. Webster MW, Scott RR. What cardiologists need to know about diabetes. Lancet 1997; 350 (Suppl 1): 23-28. Go to original source... Go to PubMed...
  2. Nesto R. Angina and exertional myocardial ischaemia in diabetic and nondiabetic patients. Assesment by exercise thallium scintigraphy. Ann Intern Med 1988; 108: 170-175. Go to original source... Go to PubMed...
  3. Charvát J, Kolbel F, Michalová K et al. Asymptomatická ischemická choroba srdeční u nemocných s diabetes mellitus. DMEV 2004; 7: 109-116.
  4. Charvát J, Michalová K, Táborská K et al. Comparison of the exercise ECG and stress myocardial SPECT in detection of the significant coronary artery disease in the asymptomatic patients with diabetes mellitus type 2. Bratisl Lek Listy 2004; 105: 56-61. Go to PubMed...
  5. Charvát J, Michalová K, Táborská K et al. Vztah kompenzace diabetu, přítomnosti albuminurie a některých biochemických parametrů k výsledku zátěžového SPECT - u myokardu u asymptomatických diabetiků 2. typu. Vnitř Lék 2004; 50: 894-900. Go to PubMed...
  6. Charvát J, Michalová K, Táborská K et al. Vztah echokardiografického vyšetření a sonografie karotické tepny k výsledku zátěžového SPECT myokardu u asymptomatických nemocných s diabetes mellitus 2. typu. Cor Vasa 2004; 46: 371-378.
  7. Faglia E, Favales F, Calia P et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease. 5-years follow-up report from Milan Study on Atherosclerosis and Diabetes (MiSAD), Diabetes Care 2002; 25: 2032-2036. Go to original source... Go to PubMed...
  8. Paramo JA, Orbe J, Beloqui O et al. Prothrombin fragment 1+2 is associated with carotid-media thickness in subjects free of clinical cardiovascular disease. Stroke 2004; 35: 1085-1089. Go to original source... Go to PubMed...
  9. Hachamovitch R, Berman S, Kiat H et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use for stratification. Circulation 1996; 93: 905-914. Go to original source... Go to PubMed...
  10. De Lorenzo A, Lima RS, Siquiera-Filha AG et al. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90: 827-832. Go to original source... Go to PubMed...
  11. Janand-Delenne B, Savin B, Habib G et al. Silent myocardial ischemia in patients with diabetes: Who to screen. Diabetes Care 199; 22: 1396-1400. Go to original source... Go to PubMed...
  12. Bacci S, Villela M, Villela A et al. Screening of silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic factors: applicability and accuracy of the exercise test. Eur J Endocrinol 2002; 147: 649-654. Go to original source... Go to PubMed...
  13. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998; 21: 1551-1559. Go to original source... Go to PubMed...
  14. Cosson E, Attali J, Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful? Diabetes Metab 2005; 31: 47-54. Go to original source... Go to PubMed...
  15. Rutter MK, McComb JM, Brady S et al. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 1999; 83: 27-31. Go to original source... Go to PubMed...
  16. Piot C, Fontbonne A, Sultan A et al. Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia. Diabetes Care 2003; 26: 545-546. Go to original source... Go to PubMed...
  17. Streja D, Cressey P, Rabkin SW. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications 2003; 17: 120-127. Go to original source... Go to PubMed...
  18. Paramo JA, Beloqui O, Roncal C et al. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease. Haematologica 2004; 89: 1226-1231. Go to PubMed...
  19. Nossen JM, Vierzigmann T, Lang E. Calcified plaques of extracranial carotid arteries and left ventricular geometry as predictors of coronary artery disease. Med Klin 2003; 98: 72-78. Go to original source... Go to PubMed...
  20. Boucher B, Ceresier A, Bouchou K et al. Silent myocardial ischemia in type 2 diabetes. Predictive value of intima-media thickness. Presse Med 2002; 31: 218-222. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.